Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01754363 · ClinicalTrials.gov registry record · NA

Survivorship of Attune Primary Total Knee Prosthesis

A NA study of Noninflammatory Degenerative Joint Disease, sponsored by DePuy International.

Active
Registry status
NA
Development phase
1,542
Enrollment target
20
Study locations

NCT01754363 is a NA study of Noninflammatory Degenerative Joint Disease that is active but no longer recruiting, run by DePuy International. The registered enrollment target is 1,542 participants. The trial reports 20 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01754363, a NA study of Noninflammatory Degenerative Joint Disease, is active but no longer recruiting, sponsored by DePuy International.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,542 participants
Enrollment target
20
Study locations

Study Summary

This post-marketing investigation will evaluate the long term (up to 15 years) survivorship of the Attune Primary Knee Prosthesis in patients with non-inflammatory degenerative joint disease. Data from Subjects who receive one of four knee configurations will be pooled to establish a contemporary dataset.

Interventions

  • DEVICE Attune Primary Total Knee Replacement

Study Locations (20)

Other

  • Monica Camputs O.L.V. Middelares - Antwerp
  • UniversitatsKlinikum Heidelberg - Heidelberg
  • Queen Mary Hospital - Hong Kong
  • University Malaya Medical Centre - Kuala Lumpur
  • Ascot Hospital - Auckland

Ohio

  • Orthopedic One - Columbus
  • OrthoNeuro - New Albany

Arizona

  • Mayo Clinic Arizona - Scottsdale

California

  • Orthopaedic Specialty Institute - Orange

Florida

  • Florida Research Associates, LLC - DeLand

Indiana

  • Center for Hip and Knee Surgery - Mooresville

Iowa

  • University of Iowa Hospitals & Clinics - Iowa City

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 1,542 participants
Start Date 2013-02-01
Est. Completion 2030-02-01
Phase NA

Sponsor

DePuy International

2 total trials

What the Registry Record Tells You About NCT01754363

The ClinicalTrials.gov registry entry for NCT01754363 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,542 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DePuy International, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Noninflammatory Degenerative Joint Disease appearing as the primary indexed condition, and to 1 intervention - of which Attune Primary Total Knee Replacement is the first listed.

NCT01754363 reports 20 study locations spanning 15 distinct geographic areas - top geographies include Other, Ohio, Arizona.

Frequently Asked Questions

What is clinical trial NCT01754363 about?

NCT01754363 is a clinical study titled "Survivorship of Attune Primary Total Knee Prosthesis". This post-marketing investigation will evaluate the long term (up to 15 years) survivorship of the Attune Primary Knee Prosthesis in patients with non-inflammatory degenerative joint disease. Data from Subjects who receive one of four knee configurations will be pooled to establish a contemporary da...

What is the current status of trial NCT01754363?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,542 participants. The study started on 2013-02-01. Estimated completion is 2030-02-01.

What conditions does trial NCT01754363 study?

This clinical trial studies the following conditions: Noninflammatory Degenerative Joint Disease.

What interventions are being tested in trial NCT01754363?

The interventions under investigation include: Attune Primary Total Knee Replacement (DEVICE).

Who is sponsoring clinical trial NCT01754363?

This trial is sponsored by DePuy International, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01754363 being conducted?

This trial has 20 study locations across Arizona, California, Florida, Indiana, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.